Health Care/Hospital

Pudu Robotics to Showcase Comprehensive Solutions at Australian Healthcare Week

SYDNEY, March 8, 2024 /PRNewswire/ -- Pudu Robotics ("PUDU"), the global leader in commercial service robots, is excited to announce its participation in the forthcoming Australian Healthcare Week (AHW), the biggest and most influential healthcare gathering in the southern hemisphere, scheduled f...

2024-03-08 08:00 2091

P2G Foundation is Leading the Charge in Empowering Singapore's Homeless Population

SINGAPORE, March 7, 2024 /PRNewswire/ -- P2G Foundation announces its commitment to empowering lives and fostering hope forSingapore's unhoused population. With an unshakable commitment to extending support and creating pathways to opportunity, P2G Foundation emerges as a guiding light of compas...

2024-03-07 15:19 1859

Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024

ROCKVILLIE, Md. and SUZHOU, China, March 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and...

2024-03-07 11:53 2380

Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

Reshaping the landscape for the second-line treatments of Small Cell Lung Cancer HONG KONG and MACAO, March 7, 2024 /PRNewswire/ -- A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer Therapy Society (HKCTS) with support from Luye Phar...

2024-03-07 10:11 1901

A Global Milestone in Innovative Pancreatic Cancer Therapy

Suppression of pancreatic cancer and increased survival rates in animals implanted with human pancreatic cancer cells when treated with biologic agent BGX, a proprietary targeted therapy developed in-house by BioGate. TAIPEI, March 7, 2024 /PRNewswire/ -- BioGate Precision Medicine Corp., a memb...

2024-03-07 10:00 1705

Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance

CAESAREA, Israel, March 7, 2024 /PRNewswire/ -- Epitomee® (TASE: EPIT) announced today that onFebruary 27, 2024, it has submitted its Weight Loss Capsule for FDA clearance in theUSA, reaching a significant milestone in the company's journey. The Epitomee® capsule offers an innovative, orally adm...

2024-03-07 09:00 1446

APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation

SINGAPORE, March 6, 2024 /PRNewswire/ -- APAX Medical & Aesthetics Clinic is proud to announce the introduction of the ADVATx laser treatment by Advalight in their offerings - a revolutionary laser system that targets both active acne and acne scars simultaneously. This innovative solution utilis...

2024-03-06 20:22 1646

Latest Updates of Viva Biotech's Portfolio Companies

HONG KONG, March 6, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...

2024-03-06 19:33 1561

American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya

Project will combat infant mortality rates and lessen fetal distress in East Africa TATU CITY, Kenya, March 6, 2024 /PRNewswire/ -- The governments of the United States, Finland and Canada are funding a sustainable, accessible and affordable medicinal oxygen manufacturing facility at Tatu City S...

2024-03-06 18:48 1665

MAG GROUP HOLDING RECORDS OVER AED 12.6 BILLION SALES IN 2023

DUBAI, UAE, March 6, 2024 /PRNewswire/ -- MAG Group Holding, the multinational conglomerate incorporating different companies across diverse sectors, announced the recording of AED 12.6 billion in sales for 2023 across its different real estate subsidiaries.

2024-03-06 18:00 2234

NIPPON EXPRESS HOLDINGS Acquires Stake in Instalimb, Japan's Startup Expanding 3D-printed Prosthetics Business Overseas

- Helping to Achieve Sustainable Societies Allowing All People to Lead Affluent and Fulfilling Lives - TOKYO, March 6, 2024 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. acquired an equity stake in Instalimb, Inc. (hereinafter "Instalimb"), which is expanding its 3D-printed prosthetics business ...

2024-03-06 14:00 1631

Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision

Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors MIAMI and PERTH, Australia, March 6, 2024 /PRNewswire/ -- Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced today the appointment ofMark W...

2024-03-06 12:29 1636

Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024

SHANGHAI, March 6, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will report financial results for the fu...

2024-03-06 08:59 1624

Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma

The independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This follows the previous recommendation in relation to safety. CLINGLIO remains on track to have its op...

2024-03-06 08:45 1779

Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms

* The first preclinical abstract on ATG-O42 (MTAPnull-selective small molecule PRMT5 inhibitor) as well as the latest data on the proprietary T cell engager platform, AnTenGagerTM, and ATG-102 (LILRB4 x CD3 T cell engager). * The first view of ATG-022 (Claudin 18.2 ADC) companion diagnostic. S...

2024-03-06 08:30 1826

Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024

* Presentations will highlight the broad potential treatment opportunities for its clinical-stage targeted therapeutics HMBD-001 (anti-HER3 mAb) and HMBD-002 (anti-VISTA mAb) with further demonstrations of their pre-clinical efficacy in additional indications and deeper studies of their underly...

2024-03-06 05:30 1712

Life Fitness Delivers on the Future of Fitness, Debuting State-of-the-Art Cardio Line with Next-Gen Biomechanics, Symbio™, at IHRSA 2024

ROSEMONT, Ill., March 6, 2024 /PRNewswire/ -- Life Fitness, the global leader in commercial fitness equipment, will unveil a new generation of cardio, strength training, and digital product innovations at the 2024 IHRSA Convention & Trade Show. Life Fitness' latest innovations builds on the compa...

2024-03-06 00:00 2716

Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production

IRVINE, Calif., March 5, 2024 /PRNewswire/ -- In a groundbreaking development, Zymo Research, a leader in biotechnology innovation, has revolutionized large-scale production of animal-free recombinant RNase A ( PureRec RNase A), a challenge that persisted for over half a century. This breakthroug...

2024-03-05 22:00 1334

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Expansion would make DaVita the largest dialysis services provider in Latin America DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations inBrazil and ...

2024-03-05 22:00 3211

Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins

SHANGHAI, March 5, 2024 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, recently successfully hosted a webinar event with Protein Production Technology International (PPTI), a digital publication dedicated to the alternative proteins sp...

2024-03-05 21:00 1726
1 ... 567891011 ... 551

Week's Top Stories